Junping Shi
Impact in
- Hepatology top 1%
- Liver Disease and Transplantation
- Hepatitis C virus research
- Epidemiology top 1%
- Liver Disease Diagnosis and Treatment
- Hepatitis B Virus Studies
Papers in
- Epidemiology 97
- Liver Disease Diagnosis and Treatment 91
- Hepatitis B Virus Studies 13
-
- Gut microbiota and health 6
- Co-authors
- Jian‐Gao Fan (18 shared papers)Lun Gen Lu (2 shared papers)You Ming Li (2 shared papers)Shufei Zang (15 shared papers)Jin Yang (8 shared papers)Yunhao Xun (25 shared papers)Yan Luo (13 shared papers)Wenjun Yang (21 shared papers)
- Journals
- Clinical and Experimental Pharmacology and Physiology (4 papers)Journal of Hepatology (4 papers)Advances in Therapy (3 papers)Alimentary Pharmacology & Therapeutics (3 papers)Aging (3 papers)
- Partner nations
- ChinaHong KongUnited States
In The Last Decade
Junping Shi
155 papers receiving 3.4k citations
Junping Shi's Hit Papers
Peers
Comparison fields: 5 of 103
- Hepatology 492
- Epidemiology 1.7k
- Endocrinology, Diabetes and Metabolism 478
- Cancer Research 245
- Biochemistry 96
Countries citing papers authored by Junping Shi
This map shows the geographic impact of Junping Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junping Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junping Shi more than expected).
Fields of papers citing papers by Junping Shi
This network shows the impact of papers produced by Junping Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junping Shi. The network helps show where Junping Shi may publish in the future.
Co-authors
The 25 scholars most cited alongside Junping Shi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 167 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 237 | |
| 2 | Lactylation, a Novel Metabolic Reprogramming Code: Current Status and Prospects Hit paper breakdown → | 2021 | 234 |
| 3 | 2010 | 207 | |
| 4 | 2016 | 162 | |
| 5 | 2017 | 136 | |
| 6 | 2019 | 135 | |
| 7 | 2015 | 117 | |
| 8 | 2019 | 113 | |
| 9 | 2008 | 88 | |
| 10 | 2022 | 80 | |
| 11 | 2022 | 72 | |
| 12 | 2015 | 71 | |
| 13 | 2020 | 70 | |
| 14 | 2014 | 69 | |
| 15 | 2015 | 63 | |
| 16 | Berberine prevents non-alcoholic steatohepatitis-derived hepatocellular carcinoma by inhibiting inflammation and angiogenesis in mice. | 2019 | 63 |
| 17 | 2016 | 53 | |
| 18 | 2017 | 48 | |
| 19 | 2016 | 45 | |
| 20 | 2019 | 42 |
About Junping Shi
Junping Shi is a scholar working on Epidemiology, Molecular Biology, Hepatology, Endocrinology, Diabetes and Metabolism and Pathology and Forensic Medicine, having authored 167 papers that have together received 3.4k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (91 papers), Diet, Metabolism, and Disease (15 papers), Hepatitis B Virus Studies (13 papers), Liver Disease and Transplantation (12 papers), Alcohol Consumption and Health Effects (10 papers), Lipid metabolism and disorders (7 papers), Gut microbiota and health (6 papers) and Hepatitis C virus research (6 papers). The work is most often cited by research in Hepatology (492 citations), Epidemiology (1.7k citations), Endocrinology, Diabetes and Metabolism (478 citations), Cancer Research (245 citations) and Biochemistry (96 citations). Junping Shi has collaborated with scholars based in China, Hong Kong and United States. Frequent co-authors include Jian‐Gao Fan, Lun Gen Lu, You Ming Li, Shufei Zang, Jin Yang, Yunhao Xun, Yan Luo, Wenjun Yang, Ji Dong Jia and Yuhan Yang. Their work appears in journals such as Clinical and Experimental Pharmacology and Physiology, Journal of Hepatology, Advances in Therapy, Alimentary Pharmacology & Therapeutics and Aging.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.